3 Stocks to Get on Your Watchlist: Oplink Communications, Inc. (OPLK) and More

Nexafed, however, looks like it could be a whole different animal for Acura. Nexafed is a new version of the decongestant pseudoephedrine that utilizes Acura’s technology and disallows users who wish to extract the pseudoephedrine to turn it into crystal meth from doing so. As my Fool colleague David Williamson notes, the key growth driver for Acura moving forward is the fact that it owns all rights to Nexafed. With relatively low research and development costs, Nexafed should be enough to move Acura into the black without the need for Oxecta royalties. This is a biotech worth keeping a close eye on.

Cameco Corporation (USA) (NYSE:CCJ)
To say that the bottom-line results for uranium producers have been affected in a negative way because of rising nuclear energy costs and the tragic Japanese earthquake of 2011 would be an understatement. Cameco, one of the world’s largest uranium producers, recently delivered its full-year results that highlighted a 12% decline in adjusted earnings on a 3% fall in revenue. Uranium prices fell 4% as domestic nuclear projects continue to be delayed or canceled altogether.

However, you’ll find very few companies as transparent as Cameco when it comes to laying out its projections for up to five years down the road. Production in 2013 is expected to expand to 23.2 million pounds as its Cigar Lake mine finally comes online. By 2016, production should be up to more than 31 million pounds of uranium, with Cigar Lake producing close to 8 million pounds alone.

The price of uranium should also stabilize and head higher as the Obama administration pushes energy producers for cleaner fuels and Cameco looks overseas for opportunities. Nuclear energy has received a bad rap lately and could be turned to via energy subsidies as a way to make America energy-independent. In China, nuclear energy looks poised to become a big energy driver along with coal over the next decade. Cameco may be down now, but it won’t be down for long.

The article 3 Stocks to Get on Your Watchlist originally appeared on Fool.com and is written by Sean Williams.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. He’s a total nerd when it comes to making lists. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.